Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-08

Clinical Trial Update: Safety Study of Chimeric Vaccine to Prevent ETEC Diarrhea [Phase 1]

View source ↗

Summary

Phase 1 safety study of a chimeric vaccine to prevent ETEC diarrhea has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chimeric vaccine to prevent ETEC diarrhea

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Escherichia Coli Infection | Phase 1 | Status: COMPLETED | Results posted: 2019-07-08